ArticleFrontiers in oncology2024

Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer.

Margaret M Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.